Cutting through traditional silos in contract pharmaceutical research & clinical pharmacology services.
Looking for a CRO?
Quotient Sciences are a global drug development and manufacturing accelerator that partners with pharma and biotechs of all sizes to move pharmaceutical research and clinical testing forward.
Guided by our principles, we work together with our clients to cut through siloes and turn novel molecules into medicines of the future.
Translational Pharmaceutics® platform for integrated clinical testing and drug development
The Translational Pharmaceutics® platform compresses drug formulation, development, and clinical testing timelines while ensuring better data-driven decision-making and streamlined outsourcing.
- Translational Pharmaceutics® for accelerating first-in-human, Phase I clinical testing: Reach a pivotal milestone with our phase-specific drug product to test the safety and tolerability of your drug when Translational Pharmaceutics® is applied for your first-in-human clinical trials.
- Translational Pharmaceutics® for drug product optimization in Phase Ib/IIa clinical studies: Simplify reformulation after Phase I and beyond to manage product lifecycle, ensure continued innovation, and meet trial success.
- Translational Pharmaceutics® for more efficient human ADME studies: Whether conducting human ADME for New Drug Applications (NDA) or running in parallel with Phase II Proof of Concept (POC) studies, we can help you achieve your milestones faster.
Explore our CRO services and CDMO services for clinical testing, drug product formulation development, clinical trial materials manufacturing, and more.
Where are Quotient Sciences CRO services based?
From facilities located in the US and UK, Quotient Sciences offers coordinated contract research, development, and manufacturing services (CRO services and CDMO services) as part of one organization. Phase I clinical testing and clinical pharmacology services are done from facilities in Nottingham, UK and Miami, FL.
What is the objective of clinical pharmacology?
Clinical pharmacology involves the study of drugs in either healthy volunteers or patients. At Quotient Sciences, our clinical pharmacology services cover all aspects of Phase I clinical trials, including trial design, project management, and medical writing (such as synopses and clinical protocols). We can support study types including first in human (FIH), including SAD/MAD, bioavailability/pharmacokinetics, bioequivalence (BE), biosimilars, pharmacodynamic/biomarker, food effect (FE), drug-drug interaction (DDI), cardiac monitoring/Thorough QT (TQT), human ADME, microdose/microtracer, and ethnobridging.
What does clinical pharmacology involve?
Clinical pharmacology involves the study of drugs in either healthy volunteers or patients. At Quotient Sciences, our clinical pharmacology services cover all aspects of Phase I clinical trials, including trial design, project management, and medical writing (such as synopses and clinical protocols). We also handle regulatory submissions, project management, subject recruitment and screening for healthy volunteer studies, and offer pharmacy compounding services at our Miami, FL CRO facility. Our expertise extends to clinical conduct, data management, pharmacokinetics, and statistical analysis, including clinical and statistical programming. Additionally, we provide vendor management and ensure quality oversight throughout the entire process to guarantee successful trial execution and compliance.
How is a CRDMO different from a CRO?
Contract research and manufacturing services are often separate services. Simply put, a company that offers CRDMO services integrates different areas that would typically be found by selecting multiple vendors. A CRDMO offers a contract research, development, and manufacturing as part of one organization.